Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1366 AL 1380

Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis

Gultekin E, Bekircan O, Kolcuoğlu Y, Akdemir A.

Arch Pharm (Weinheim). 2021 Aug;354(8):e2100058. doi: 10.1002/ardp.202100058. Epub 2021 Apr 26.

Episodic headache with spontaneous hypothermia reveal Shapiro's syndrome variant with effectiveness of clonidine therapy

Aubignat M, Tir M, Krystkowiak P, Andriuta D.

J Headache Pain. 2021 Apr 26;22(1):30. doi: 10.1186/s10194-021-01245-3.

Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease

De Bernardo M, Salerno G, Gioia M, Capasso L, Russillo MC, Picillo M, Erro R, Amboni M, Barone P, Rosa N, Pellecchia MT.

Sci Rep. 2021 Apr 26;11(1):8936. doi: 10.1038/s41598-021-88250-3.

Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy

Sarangi SC, Sopory P, Reeta KH.

Neurol India. 2021 Mar-Apr;69(2):252-259. doi: 10.4103/0028-3886.314522.

A Systematic Review and Meta-analysis of Prevalence of Epilepsy, Dementia, Headache, and Parkinson Disease in India

Dhiman V, Menon GR, Kaur S, Mishra A, John D, Rao Vishnu MV, Tiwari RR, Dhaliwal RS.

Neurol India. 2021 Mar-Apr;69(2):294-301. doi: 10.4103/0028-3886.314588.

Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial

Schmidt N, Tödt I, Berg D, Schlenstedt C, Folkerts AK, Ophey A, Dimenshteyn K, Elben S, Wojtecki L, Liepelt-Scarfone I, Schulte C, Sulzer P, Eggers C, Kalbe E, Witt K.

J Neurol. 2021 Dec;268(12):4655-4666. doi: 10.1007/s00415-021-10568-9. Epub 2021 Apr 27.

The role of dopamine in action control: Insights from medication effects in Parkinson's disease

Ruitenberg MFL, van Wouwe NC, Wylie SA, Abrahamse EL.

Neurosci Biobehav Rev. 2021 Aug;127:158-170. doi: 10.1016/j.neubiorev.2021.04.023. Epub 2021 Apr 24.

Potential roles of gut microbiota and microbial metabolites in Parkinson's disease

Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD.

Ageing Res Rev. 2021 Aug;69:101347. doi: 10.1016/j.arr.2021.101347. Epub 2021 Apr 24.

Lithium beyond psychiatric indications: the reincarnation of a new old drug

Haupt M, Bähr M, Doeppner TR.

Neural Regen Res. 2021 Dec;16(12):2383-2387. doi: 10.4103/1673-5374.313015.

Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study

Fasano A, Gurevich T, Jech R, Kovács N, Svenningsson P, Szász J, Parra JC, Bergmann L, Johnson A, Sanchez-Soliño O, Tang Z, Vela-Desojo L.

Mov Disord. 2021 Aug;36(8):1853-1862. doi: 10.1002/mds.28596. Epub 2021 Apr 28.

Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease

Jensen BR, Malling ASB, Schmidt SI, Meyer M, Morberg BM, Wermuth L.

PLoS One. 2021 Apr 28;16(4):e0248800. doi: 10.1371/journal.pone.0248800. eCollection 2021.

The Cellular Prion Protein-ROCK Connection: Contribution to Neuronal Homeostasis and Neurodegenerative Diseases

Schneider B, Baudry A, Pietri M, Alleaume-Butaux A, Bizingre C, Nioche P, Kellermann O, Launay JM.

Front Cell Neurosci. 2021 Apr 12;15:660683. doi: 10.3389/fncel.2021.660683. eCollection 2021.

Punding Behavior as a Red Flag for Dementia in a Patient With Depression: Case Report

Pouchon A, Dondé C, Polosan M.

Front Psychiatry. 2021 Apr 12;12:637861. doi: 10.3389/fpsyt.2021.637861. eCollection 2021.

Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis

Cho SJ, Bae YJ, Kim JM, Kim HJ, Baik SH, Sunwoo L, Choi BS, Jung C, Kim JH.

J Neurol. 2021 Dec;268(12):4721-4736. doi: 10.1007/s00415-021-10582-x. Epub 2021 Apr 29.

Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease

Bortolozzi A, Manashirov S, Chen A, Artigas F.

Pharmacol Ther. 2021 Nov;227:107873. doi: 10.1016/j.pharmthera.2021.107873. Epub 2021 Apr 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias